Real-time enrollment status for this macular degeneration clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 10:49 PM UTC
| NCT Number | NCT04853251 |
| Recruiting Status | Recruiting |
| Condition | Macular Degeneration |
| Phase | PHASE4 |
| Target Enrollment | 188 participants |
| Active Locations | 52 sites in the US |
| Sponsor | Genentech, Inc. |
| Last Updated on CT.gov | July 10, 2026 (1 week ago) |
As of July 18, 2026: Clinical trial NCT04853251 is currently recruiting participants. This phase4 study for macular degeneration is actively seeking new participants at 52 locations across the United States. The study is sponsored by Genentech, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04853251 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 52 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04853251 was last updated 1 week ago (July 10, 2026). HelloStudys verifies this status automatically.